BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10954005)

  • 1. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.
    Luchner A; Burnett JC; Jougasaki M; Hense HW; Heid IM; Muders F; Riegger GA; Schunkert H
    J Hypertens; 2000 Aug; 18(8):1121-8. PubMed ID: 10954005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
    Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
    JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy.
    Lukowicz TV; Fischer M; Hense HW; Döring A; Stritzke J; Riegger G; Schunkert H; Luchner A;
    Eur J Heart Fail; 2005 Jun; 7(4):525-31. PubMed ID: 15921790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension.
    Conen D; Zeller A; Pfisterer M; Martina B
    Am J Cardiol; 2006 Jan; 97(2):249-52. PubMed ID: 16442372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.
    Maisel AS; Koon J; Krishnaswamy P; Kazenegra R; Clopton P; Gardetto N; Morrisey R; Garcia A; Chiu A; De Maria A
    Am Heart J; 2001 Mar; 141(3):367-74. PubMed ID: 11231433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.
    Lubien E; DeMaria A; Krishnaswamy P; Clopton P; Koon J; Kazanegra R; Gardetto N; Wanner E; Maisel AS
    Circulation; 2002 Feb; 105(5):595-601. PubMed ID: 11827925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients].
    Pfister R; Scholz M; Wielckens K; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2605-9. PubMed ID: 12469271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction.
    Luchner A; Muders F; Dietl O; Friedrich E; Blumberg F; Protter AA; Riegger GA; Elsner D
    Cardiovasc Res; 2001 Aug; 51(3):601-7. PubMed ID: 11476751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study.
    Luchner A; Bröckel U; Muscholl M; Hense HW; Döring A; Riegger GA; Schunkert H
    Cardiovasc Res; 2002 Feb; 53(3):720-7. PubMed ID: 11861042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients.
    Valle R; Bagolin E; Canali C; Giovinazzo P; Barro S; Aspromonte N; Carbonieri E; Milani L
    Eur J Echocardiogr; 2006 Jan; 7(1):40-4. PubMed ID: 15886060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
    Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
    J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
    Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.
    Nakamura M; Endo H; Nasu M; Arakawa N; Segawa T; Hiramori K
    Heart; 2002 Feb; 87(2):131-5. PubMed ID: 11796549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.
    Muders F; Kromer EP; Griese DP; Pfeifer M; Hense HW; Riegger GA; Elsner D
    Am Heart J; 1997 Sep; 134(3):442-9. PubMed ID: 9327700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.